Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:33 PM UTC
| NCT Number | NCT06479135 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 58 sites in the US |
| Sponsor | Kartos Therapeutics, Inc. |
| Last Updated on CT.gov | September 25, 2025 (Sep 25, 2025) |
As of July 17, 2026: Clinical trial NCT06479135 is currently recruiting participants. This phase3 study for myelofibrosis is actively seeking new participants at 58 locations across the United States. The study is sponsored by Kartos Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06479135 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06479135 was last updated Sep 25, 2025 (September 25, 2025). HelloStudys verifies this status automatically.